biosimilars

Oncology Forecasting Training Dates Released for New Jersey

https://pharmaphorum.com/partner-content/oncology-forecasting-training-dates-released-for-new-jersey/

New Dates Released for J+D’s Pharma Forecasting Training

https://pharmaphorum.com/partner-content/new-dates-released-for-jds-pharma-forecasting-training/

Fundamentals of Forecasting Training – New Jersey

https://pharmaphorum.com/events/fundamentals-of-forecasting-training-new-jersey/

Oncology Forecasting Training New Jersey

https://pharmaphorum.com/events/oncology-forecasting-training-new-jersey/

Nine pharma trends for 2020

https://pharmaphorum.com/views-analysis-digital/nine-pharma-trends-for-2020/

The 4 biggest pharma market access stories of 2019

https://pharmaphorum.com/views-analysis-market-access/the-4-biggest-pharma-market-access-stories-of-2019/

Nine for 2019: how did we do on our predictions, and what does this mean for 2020?

https://pharmaphorum.com/views-and-analysis/nine-for-2019-2020/

https://pharmaphorum.com/news/us-eyes-shorter-exclusivity-for-biologic-drugs-in-trade-pact-report/

Celltrion gears up for subcutaneous infliximab launch in Europe

https://pharmaphorum.com/views-analysis-market-access/celltrion-gears-up-for-subcutaneous-infliximab-launch-in-europe/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search